Access cutting-edge hepatitis d treatment through this clinical trial at a research site in Cities In Iowa. Study-provided care at no cost to qualified participants.
Access hepatitis d specialists in Cities In Iowa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatitis d treatment provided free
This is a Phase 2b/3 study designed to evaluate the safety and efficacy of chronic treatment with brelovitug (a.k.a BJT-778; BTG) for chronic hepatitis delta virus (HDV) infection. The comparator in this study will be 24-weeks of delayed treatment. During the 24-weeks of delayed treatment, participants will complete the same visits and assessments as those randomized to initiate brelovitug immediately. At the completion of 24-week delayed treatment period, all participants will start treatment w
Sponsor: Bluejay Therapeutics, Inc.
Check if you qualify for this hepatitis d clinical trial in Cities In Iowa, IA
If you're searching for hepatitis d treatment options in Cities In Iowa, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cities In Iowa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatitis d specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.